KP Tissue Inc.
KPTSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.23 | 352.79 | 0.01 | -0.49 |
| FCF Yield | 0.00% | 7.79% | -10.02% | 1.15% |
| EV / EBITDA | 0.31 | 375.60 | 0.89 | -312.16 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 1.54% | 0.00% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | – | -1.41 | 1.01 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -100.00% | 167.64% | -997.05% | 147.15% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.13 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |